Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St headed for weekly gains as earnings season nears
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Elite Pharmaceuticals, Inc. (AMEX: ELTP) | Delayed: 0.26 -0.01 (3.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.27 | 52 Week High | $0.42 | |||
| Open | $0.26 | 52 Week Low | $0.11 | |||
| Day High | $0.27 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $-0.02 | |||
| Volume | 597,999 | |||||
